

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.69323359 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.59511745 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.59511745 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.43635536 |
| 5 | glycosphingolipid catabolic process (GO:0046479) | 4.19836237 |
| 6 | oligosaccharide catabolic process (GO:0009313) | 3.97831824 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.94641705 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.94641705 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 3.94641705 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 3.94641705 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 3.94641705 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.94641705 |
| 13 | immunoglobulin mediated immune response (GO:0016064) | 3.94417612 |
| 14 | neutrophil activation involved in immune response (GO:0002283) | 3.93961470 |
| 15 | glycolipid catabolic process (GO:0019377) | 3.84013482 |
| 16 | response to peptidoglycan (GO:0032494) | 3.76634450 |
| 17 | polyketide metabolic process (GO:0030638) | 3.73074158 |
| 18 | doxorubicin metabolic process (GO:0044598) | 3.73074158 |
| 19 | daunorubicin metabolic process (GO:0044597) | 3.73074158 |
| 20 | negative regulation of cell killing (GO:0031342) | 3.63446669 |
| 21 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.63446669 |
| 22 | positive regulation of interferon-alpha production (GO:0032727) | 3.59159105 |
| 23 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.51429293 |
| 24 | regulation of interferon-alpha production (GO:0032647) | 3.42730827 |
| 25 | amino sugar catabolic process (GO:0046348) | 3.35668575 |
| 26 | B cell mediated immunity (GO:0019724) | 3.34698152 |
| 27 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.30999916 |
| 28 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.29423639 |
| 29 | ceramide catabolic process (GO:0046514) | 3.27994820 |
| 30 | cellular extravasation (GO:0045123) | 3.26457177 |
| 31 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.19787556 |
| 32 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.16486149 |
| 33 | regulation of mononuclear cell migration (GO:0071675) | 3.13259806 |
| 34 | regulation of superoxide anion generation (GO:0032928) | 3.12412763 |
| 35 | detection of other organism (GO:0098543) | 3.11018308 |
| 36 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.09276970 |
| 37 | regulation of mast cell degranulation (GO:0043304) | 3.06630163 |
| 38 | response to thyroid hormone (GO:0097066) | 3.05472921 |
| 39 | interferon-gamma production (GO:0032609) | 3.05039234 |
| 40 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.04037754 |
| 41 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.00724072 |
| 42 | natural killer cell mediated immunity (GO:0002228) | 3.00724072 |
| 43 | regulation of T cell tolerance induction (GO:0002664) | 3.00602058 |
| 44 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.92244952 |
| 45 | respiratory burst (GO:0045730) | 2.89639398 |
| 46 | detection of bacterium (GO:0016045) | 2.89421613 |
| 47 | positive regulation of mast cell activation (GO:0033005) | 2.87345609 |
| 48 | regulation of leukocyte degranulation (GO:0043300) | 2.84162233 |
| 49 | leukocyte mediated cytotoxicity (GO:0001909) | 2.83216663 |
| 50 | negative regulation of phagocytosis (GO:0050765) | 2.81328176 |
| 51 | NIK/NF-kappaB signaling (GO:0038061) | 2.80881128 |
| 52 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.80494082 |
| 53 | macrophage activation involved in immune response (GO:0002281) | 2.80452367 |
| 54 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.79966264 |
| 55 | cellular response to type I interferon (GO:0071357) | 2.78081178 |
| 56 | type I interferon signaling pathway (GO:0060337) | 2.78081178 |
| 57 | response to muramyl dipeptide (GO:0032495) | 2.77835351 |
| 58 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.76944278 |
| 59 | response to type I interferon (GO:0034340) | 2.76616331 |
| 60 | positive regulation of leukocyte degranulation (GO:0043302) | 2.76456443 |
| 61 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.76394862 |
| 62 | pinocytosis (GO:0006907) | 2.73371893 |
| 63 | positive regulation of antigen processing and presentation (GO:0002579) | 2.73330719 |
| 64 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.72812235 |
| 65 | positive regulation of B cell differentiation (GO:0045579) | 2.72284915 |
| 66 | eosinophil chemotaxis (GO:0048245) | 2.71923211 |
| 67 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.71883663 |
| 68 | membrane lipid catabolic process (GO:0046466) | 2.71650576 |
| 69 | regulation of tolerance induction (GO:0002643) | 2.71617953 |
| 70 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.70955192 |
| 71 | response to interferon-beta (GO:0035456) | 2.68758833 |
| 72 | response to host immune response (GO:0052572) | 2.65668878 |
| 73 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.65668878 |
| 74 | myeloid dendritic cell differentiation (GO:0043011) | 2.64616568 |
| 75 | positive regulation of interferon-beta production (GO:0032728) | 2.63722136 |
| 76 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.63492843 |
| 77 | sphingolipid catabolic process (GO:0030149) | 2.62707621 |
| 78 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.62068343 |
| 79 | positive regulation of defense response to virus by host (GO:0002230) | 2.61700258 |
| 80 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.61643872 |
| 81 | regulation of podosome assembly (GO:0071801) | 2.61615879 |
| 82 | detection of external biotic stimulus (GO:0098581) | 2.61223581 |
| 83 | cellular response to interferon-gamma (GO:0071346) | 2.60961187 |
| 84 | regulation of chemokine biosynthetic process (GO:0045073) | 2.60065057 |
| 85 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.60021459 |
| 86 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.59502700 |
| 87 | T cell migration (GO:0072678) | 2.59092486 |
| 88 | T-helper 1 type immune response (GO:0042088) | 2.57209173 |
| 89 | positive regulation of isotype switching (GO:0045830) | 2.56624507 |
| 90 | neutrophil activation (GO:0042119) | 2.56479551 |
| 91 | myeloid dendritic cell activation (GO:0001773) | 2.56331101 |
| 92 | positive regulation of mast cell degranulation (GO:0043306) | 2.56155509 |
| 93 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.56155509 |
| 94 | response to interferon-alpha (GO:0035455) | 2.55729981 |
| 95 | protein localization to kinetochore (GO:0034501) | 2.55491993 |
| 96 | monocyte chemotaxis (GO:0002548) | 2.55427962 |
| 97 | defense response to protozoan (GO:0042832) | 2.55383570 |
| 98 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.54140305 |
| 99 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.53720717 |
| 100 | granulocyte activation (GO:0036230) | 2.53523722 |
| 101 | eosinophil migration (GO:0072677) | 2.52906246 |
| 102 | N-acetylneuraminate metabolic process (GO:0006054) | 2.52640028 |
| 103 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.51843227 |
| 104 | regulation of growth of symbiont in host (GO:0044126) | 2.51843227 |
| 105 | negative regulation of growth of symbiont in host (GO:0044130) | 2.51843227 |
| 106 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.51843227 |
| 107 | dendritic cell differentiation (GO:0097028) | 2.51822954 |
| 108 | regulation of mast cell activation (GO:0033003) | 2.51034394 |
| 109 | regulation of B cell differentiation (GO:0045577) | 2.50820749 |
| 110 | regulation of macrophage chemotaxis (GO:0010758) | 2.49938174 |
| 111 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.49829469 |
| 112 | reactive oxygen species biosynthetic process (GO:1903409) | 2.49129352 |
| 113 | regulation of antigen processing and presentation (GO:0002577) | 2.48586558 |
| 114 | negative regulation of interleukin-12 production (GO:0032695) | 2.48004823 |
| 115 | leukocyte aggregation (GO:0070486) | 2.47861750 |
| 116 | response to protozoan (GO:0001562) | 2.47711082 |
| 117 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.47456494 |
| 118 | myeloid cell activation involved in immune response (GO:0002275) | 2.47045217 |
| 119 | negative regulation of interleukin-17 production (GO:0032700) | 2.46858672 |
| 120 | peptide catabolic process (GO:0043171) | 2.46804671 |
| 121 | regulation of lymphocyte migration (GO:2000401) | 2.46757559 |
| 122 | cellular response to interferon-beta (GO:0035458) | 2.46010733 |
| 123 | pentose-phosphate shunt (GO:0006098) | 2.45552901 |
| 124 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.45002629 |
| 125 | response to interferon-gamma (GO:0034341) | 2.44497581 |
| 126 | regulation of necroptotic process (GO:0060544) | 2.44199201 |
| 127 | detection of molecule of bacterial origin (GO:0032490) | 2.43949684 |
| 128 | T cell costimulation (GO:0031295) | 2.43619355 |
| 129 | macrophage differentiation (GO:0030225) | 2.43480602 |
| 130 | regulation of response to interferon-gamma (GO:0060330) | 2.42971263 |
| 131 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.42873258 |
| 132 | lymphocyte mediated immunity (GO:0002449) | 2.39942819 |
| 133 | nuclear pore complex assembly (GO:0051292) | 2.39329193 |
| 134 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.38695666 |
| 135 | establishment of endothelial barrier (GO:0061028) | 2.38504415 |
| 136 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.38061676 |
| 137 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.37379013 |
| 138 | response to host (GO:0075136) | 2.37111212 |
| 139 | response to host defenses (GO:0052200) | 2.37111212 |
| 140 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.37111212 |
| 141 | hepatocyte apoptotic process (GO:0097284) | 2.36964433 |
| 142 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.36193060 |
| 143 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.34467887 |
| 144 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.33902861 |
| 145 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.33149166 |
| 146 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.32831809 |
| 147 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.32766333 |
| 148 | natural killer cell activation (GO:0030101) | 2.32408338 |
| 149 | regulation of gamma-delta T cell activation (GO:0046643) | 2.32128010 |
| 150 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.32020775 |
| 151 | neutrophil mediated immunity (GO:0002446) | 2.31995858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.25703162 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.48106735 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.16695229 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.83845788 |
| 5 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.07906079 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.84368435 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.51332879 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.48105639 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.45542522 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.41497891 |
| 11 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.34573149 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.34450086 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.30451250 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.28635481 |
| 15 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.28410993 |
| 16 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.18254674 |
| 17 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.15211375 |
| 18 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.08660567 |
| 19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.02325795 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.00538017 |
| 21 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.98629969 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.90978074 |
| 23 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.90616200 |
| 24 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.80713998 |
| 25 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.78989388 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.73939498 |
| 27 | MYC_22102868_ChIP-Seq_BL_Human | 1.71282489 |
| 28 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.71019325 |
| 29 | MYB_26560356_Chip-Seq_TH2_Human | 1.70628712 |
| 30 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.70593345 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.70111405 |
| 32 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.69113291 |
| 33 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.68345842 |
| 34 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.67768331 |
| 35 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.62148909 |
| 36 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61045920 |
| 37 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.60177142 |
| 38 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.60177142 |
| 39 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.60177142 |
| 40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55873318 |
| 41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.52694756 |
| 42 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.52256923 |
| 43 | MYB_26560356_Chip-Seq_TH1_Human | 1.51443806 |
| 44 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.50604210 |
| 45 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.50419447 |
| 46 | MAF_26560356_Chip-Seq_TH1_Human | 1.50277710 |
| 47 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.49351660 |
| 48 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.45062659 |
| 49 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41595275 |
| 50 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40647142 |
| 51 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.35971669 |
| 52 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.34708600 |
| 53 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.32720760 |
| 54 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.31481352 |
| 55 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.29690430 |
| 56 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.29560068 |
| 57 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.27885389 |
| 58 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26714019 |
| 59 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.23706811 |
| 60 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.23694514 |
| 61 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.23103394 |
| 62 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.21779528 |
| 63 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20687052 |
| 64 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.20416616 |
| 65 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.18005441 |
| 66 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.17245404 |
| 67 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.15838135 |
| 68 | UTX_26944678_Chip-Seq_JUKART_Human | 1.15000752 |
| 69 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.14039561 |
| 70 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13191941 |
| 71 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13105177 |
| 72 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.12752137 |
| 73 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.12328320 |
| 74 | SPI1_23127762_ChIP-Seq_K562_Human | 1.12029637 |
| 75 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.11951578 |
| 76 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10373095 |
| 77 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09056702 |
| 78 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08599911 |
| 79 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.07987143 |
| 80 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.06904035 |
| 81 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.06746130 |
| 82 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.06706030 |
| 83 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.06135871 |
| 84 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.04702325 |
| 85 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04309622 |
| 86 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.01772495 |
| 87 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.01622174 |
| 88 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.01597469 |
| 89 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.00398013 |
| 90 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.00315529 |
| 91 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.00140627 |
| 92 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.00140427 |
| 93 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.00088967 |
| 94 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.99342938 |
| 95 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.98947108 |
| 96 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.98839735 |
| 97 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.98334958 |
| 98 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97712827 |
| 99 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.97058937 |
| 100 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.95482936 |
| 101 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.95360362 |
| 102 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94370536 |
| 103 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.93547665 |
| 104 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91460243 |
| 105 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.90925974 |
| 106 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.90101405 |
| 107 | MAF_26560356_Chip-Seq_TH2_Human | 0.89556135 |
| 108 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.89528252 |
| 109 | GATA3_26560356_Chip-Seq_TH2_Human | 0.89484111 |
| 110 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.89457863 |
| 111 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.88691007 |
| 112 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.88318284 |
| 113 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.88057103 |
| 114 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.86919406 |
| 115 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.86555164 |
| 116 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86146204 |
| 117 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.86055218 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.02590894 |
| 2 | MP0003436_decreased_susceptibility_to | 3.12721061 |
| 3 | MP0009785_altered_susceptibility_to | 2.98621958 |
| 4 | MP0006082_CNS_inflammation | 2.81744541 |
| 5 | MP0005000_abnormal_immune_tolerance | 2.57687629 |
| 6 | MP0000685_abnormal_immune_system | 2.51527987 |
| 7 | MP0005671_abnormal_response_to | 2.48958344 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.44505527 |
| 9 | MP0005025_abnormal_response_to | 2.43608704 |
| 10 | MP0001790_abnormal_immune_system | 2.34923602 |
| 11 | MP0005387_immune_system_phenotype | 2.34923602 |
| 12 | MP0002419_abnormal_innate_immunity | 2.34895473 |
| 13 | MP0001800_abnormal_humoral_immune | 2.26921869 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.20747365 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.20435813 |
| 16 | MP0002723_abnormal_immune_serum | 2.12317992 |
| 17 | MP0002396_abnormal_hematopoietic_system | 2.01731393 |
| 18 | MP0001819_abnormal_immune_cell | 2.00338470 |
| 19 | MP0002420_abnormal_adaptive_immunity | 1.99765460 |
| 20 | MP0003724_increased_susceptibility_to | 1.98482480 |
| 21 | MP0001853_heart_inflammation | 1.97209276 |
| 22 | MP0005451_abnormal_body_composition | 1.97124650 |
| 23 | MP0003300_gastrointestinal_ulcer | 1.96765999 |
| 24 | MP0002254_reproductive_system_inflammat | 1.93795785 |
| 25 | MP0003303_peritoneal_inflammation | 1.92580382 |
| 26 | MP0008057_abnormal_DNA_replication | 1.85979341 |
| 27 | MP0002405_respiratory_system_inflammati | 1.85537874 |
| 28 | MP0010352_gastrointestinal_tract_polyps | 1.76701838 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 1.76169002 |
| 30 | MP0010155_abnormal_intestine_physiology | 1.70488078 |
| 31 | MP0002398_abnormal_bone_marrow | 1.69426117 |
| 32 | MP0005464_abnormal_platelet_physiology | 1.66722756 |
| 33 | MP0000716_abnormal_immune_system | 1.65597662 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.65320441 |
| 35 | MP0004947_skin_inflammation | 1.61959999 |
| 36 | MP0008260_abnormal_autophagy | 1.61209619 |
| 37 | MP0002166_altered_tumor_susceptibility | 1.60389361 |
| 38 | MP0000689_abnormal_spleen_morphology | 1.58277817 |
| 39 | MP0004264_abnormal_extraembryonic_tissu | 1.56024762 |
| 40 | MP0003186_abnormal_redox_activity | 1.54634440 |
| 41 | MP0003448_altered_tumor_morphology | 1.50670264 |
| 42 | MP0001533_abnormal_skeleton_physiology | 1.49515684 |
| 43 | MP0002429_abnormal_blood_cell | 1.48679879 |
| 44 | MP0002722_abnormal_immune_system | 1.48169675 |
| 45 | MP0008469_abnormal_protein_level | 1.48155407 |
| 46 | MP0003183_abnormal_peptide_metabolism | 1.47396591 |
| 47 | MP0003191_abnormal_cellular_cholesterol | 1.45525588 |
| 48 | MP0002006_tumorigenesis | 1.42745563 |
| 49 | MP0000490_abnormal_crypts_of | 1.42183847 |
| 50 | MP0005310_abnormal_salivary_gland | 1.41788882 |
| 51 | MP0003763_abnormal_thymus_physiology | 1.41568767 |
| 52 | MP0000858_altered_metastatic_potential | 1.40941856 |
| 53 | MP0000343_altered_response_to | 1.40833374 |
| 54 | MP0001545_abnormal_hematopoietic_system | 1.38307451 |
| 55 | MP0005397_hematopoietic_system_phenotyp | 1.38307451 |
| 56 | MP0009840_abnormal_foam_cell | 1.37226354 |
| 57 | MP0010307_abnormal_tumor_latency | 1.35185823 |
| 58 | MP0004957_abnormal_blastocyst_morpholog | 1.34225714 |
| 59 | MP0009764_decreased_sensitivity_to | 1.24688862 |
| 60 | MP0002139_abnormal_hepatobiliary_system | 1.22611601 |
| 61 | * MP0003172_abnormal_lysosome_physiology | 1.21459982 |
| 62 | MP0003566_abnormal_cell_adhesion | 1.19679307 |
| 63 | MP0005075_abnormal_melanosome_morpholog | 1.18889465 |
| 64 | MP0004782_abnormal_surfactant_physiolog | 1.18193030 |
| 65 | MP0000465_gastrointestinal_hemorrhage | 1.16928125 |
| 66 | MP0003806_abnormal_nucleotide_metabolis | 1.15270824 |
| 67 | MP0002877_abnormal_melanocyte_morpholog | 1.15024031 |
| 68 | MP0003828_pulmonary_edema | 1.14215035 |
| 69 | MP0003453_abnormal_keratinocyte_physiol | 1.08021254 |
| 70 | MP0000604_amyloidosis | 1.06975231 |
| 71 | MP0003075_altered_response_to | 1.04287742 |
| 72 | MP0004808_abnormal_hematopoietic_stem | 1.04061478 |
| 73 | MP0005166_decreased_susceptibility_to | 1.02863298 |
| 74 | MP0003693_abnormal_embryo_hatching | 1.00816552 |
| 75 | MP0002998_abnormal_bone_remodeling | 1.00524397 |
| 76 | MP0003705_abnormal_hypodermis_morpholog | 1.00355888 |
| 77 | MP0002138_abnormal_hepatobiliary_system | 0.99941622 |
| 78 | MP0003690_abnormal_glial_cell | 0.99151824 |
| 79 | MP0003011_delayed_dark_adaptation | 0.97690008 |
| 80 | MP0003077_abnormal_cell_cycle | 0.95530194 |
| 81 | MP0008007_abnormal_cellular_replicative | 0.95508594 |
| 82 | MP0005408_hypopigmentation | 0.95413362 |
| 83 | MP0001873_stomach_inflammation | 0.95402785 |
| 84 | MP0003656_abnormal_erythrocyte_physiolo | 0.94760844 |
| 85 | MP0009763_increased_sensitivity_to | 0.94206308 |
| 86 | MP0005023_abnormal_wound_healing | 0.94076682 |
| 87 | MP0002019_abnormal_tumor_incidence | 0.92059543 |
| 88 | MP0000609_abnormal_liver_physiology | 0.90968341 |
| 89 | MP0000015_abnormal_ear_pigmentation | 0.90814877 |
| 90 | MP0006054_spinal_hemorrhage | 0.90464296 |
| 91 | MP0000703_abnormal_thymus_morphology | 0.90009661 |
| 92 | MP0002277_abnormal_respiratory_mucosa | 0.87149360 |
| 93 | MP0001851_eye_inflammation | 0.85175121 |
| 94 | MP0010094_abnormal_chromosome_stability | 0.84451419 |
| 95 | MP0003329_amyloid_beta_deposits | 0.82765569 |
| 96 | MP0003866_abnormal_defecation | 0.81439403 |
| 97 | MP0004510_myositis | 0.81153383 |
| 98 | MP0000920_abnormal_myelination | 0.80132518 |
| 99 | MP0005165_increased_susceptibility_to | 0.79585186 |
| 100 | MP0002090_abnormal_vision | 0.79517607 |
| 101 | MP0002132_abnormal_respiratory_system | 0.79249947 |
| 102 | MP0000598_abnormal_liver_morphology | 0.77859368 |
| 103 | MP0000313_abnormal_cell_death | 0.76659361 |
| 104 | MP0000249_abnormal_blood_vessel | 0.75146682 |
| 105 | MP0000371_diluted_coat_color | 0.74735189 |
| 106 | MP0002332_abnormal_exercise_endurance | 0.74010484 |
| 107 | MP0010234_abnormal_vibrissa_follicle | 0.72778304 |
| 108 | MP0005390_skeleton_phenotype | 0.72562867 |
| 109 | MP0005164_abnormal_response_to | 0.72508305 |
| 110 | MP0002136_abnormal_kidney_physiology | 0.71812893 |
| 111 | MP0008873_increased_physiological_sensi | 0.71244718 |
| 112 | * MP0005319_abnormal_enzyme/_coenzyme | 0.70900946 |
| 113 | MP0003795_abnormal_bone_structure | 0.70582297 |
| 114 | MP0000350_abnormal_cell_proliferation | 0.69387596 |
| 115 | MP0009278_abnormal_bone_marrow | 0.69212479 |
| 116 | MP0003091_abnormal_cell_migration | 0.69106488 |
| 117 | MP0000358_abnormal_cell_content/ | 0.66772309 |
| 118 | MP0001849_ear_inflammation | 0.64146892 |
| 119 | MP0000372_irregular_coat_pigmentation | 0.63787491 |
| 120 | MP0004883_abnormal_blood_vessel | 0.62861150 |
| 121 | MP0009765_abnormal_xenobiotic_induced | 0.61656024 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.16950702 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.63140413 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.62126627 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.12582614 |
| 5 | Abnormality of macrophages (HP:0004311) | 3.80420939 |
| 6 | Myositis (HP:0100614) | 3.69766622 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 3.62045657 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.49799351 |
| 9 | Increased cerebral lipofuscin (HP:0011813) | 3.36736309 |
| 10 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.28811089 |
| 11 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.28811089 |
| 12 | Abnormality of glycolipid metabolism (HP:0010969) | 3.28811089 |
| 13 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.27984873 |
| 14 | Orchitis (HP:0100796) | 3.27319506 |
| 15 | Recurrent viral infections (HP:0004429) | 3.23934933 |
| 16 | Thrombocytosis (HP:0001894) | 3.22393546 |
| 17 | Disinhibition (HP:0000734) | 3.15686447 |
| 18 | Chronic otitis media (HP:0000389) | 3.03416463 |
| 19 | Recurrent fungal infections (HP:0002841) | 3.01912643 |
| 20 | Autoimmune thrombocytopenia (HP:0001973) | 2.99655905 |
| 21 | Mediastinal lymphadenopathy (HP:0100721) | 2.97962530 |
| 22 | Multiple enchondromatosis (HP:0005701) | 2.95824584 |
| 23 | Recurrent skin infections (HP:0001581) | 2.92507668 |
| 24 | Nasal polyposis (HP:0100582) | 2.84800423 |
| 25 | Petechiae (HP:0000967) | 2.79531353 |
| 26 | Gingivitis (HP:0000230) | 2.77716429 |
| 27 | Poor head control (HP:0002421) | 2.74773843 |
| 28 | Vasculitis (HP:0002633) | 2.66370197 |
| 29 | Abnormality of the nasal mucosa (HP:0000433) | 2.65730877 |
| 30 | Pustule (HP:0200039) | 2.64245098 |
| 31 | Abnormality of T cell physiology (HP:0011840) | 2.64028947 |
| 32 | Interstitial pulmonary disease (HP:0006530) | 2.64009807 |
| 33 | Periodontitis (HP:0000704) | 2.61433219 |
| 34 | IgM deficiency (HP:0002850) | 2.58478094 |
| 35 | Increased IgM level (HP:0003496) | 2.56915571 |
| 36 | Vertebral compression fractures (HP:0002953) | 2.48905572 |
| 37 | Dysostosis multiplex (HP:0000943) | 2.46965739 |
| 38 | Pulmonary infiltrates (HP:0002113) | 2.44699902 |
| 39 | Cellulitis (HP:0100658) | 2.42673449 |
| 40 | Systemic lupus erythematosus (HP:0002725) | 2.42189177 |
| 41 | Progressive neurologic deterioration (HP:0002344) | 2.41766671 |
| 42 | Chronic obstructive pulmonary disease (HP:0006510) | 2.39077158 |
| 43 | Obstructive lung disease (HP:0006536) | 2.39077158 |
| 44 | Stomatitis (HP:0010280) | 2.38948062 |
| 45 | Agnosia (HP:0010524) | 2.38533428 |
| 46 | Leukocytosis (HP:0001974) | 2.36770042 |
| 47 | Increased serum ferritin (HP:0003281) | 2.36374255 |
| 48 | Abnormality of T cells (HP:0002843) | 2.35623136 |
| 49 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.35265649 |
| 50 | Hematochezia (HP:0002573) | 2.31826254 |
| 51 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.29475767 |
| 52 | Osteolytic defects of the hand bones (HP:0009699) | 2.29475767 |
| 53 | Gingival bleeding (HP:0000225) | 2.28572731 |
| 54 | Reduced antithrombin III activity (HP:0001976) | 2.28314025 |
| 55 | Combined immunodeficiency (HP:0005387) | 2.27390075 |
| 56 | Basal ganglia calcification (HP:0002135) | 2.26987097 |
| 57 | Mucopolysacchariduria (HP:0008155) | 2.25502752 |
| 58 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.25502752 |
| 59 | Spontaneous hematomas (HP:0007420) | 2.25034738 |
| 60 | Peritonitis (HP:0002586) | 2.24873535 |
| 61 | Mutism (HP:0002300) | 2.24053188 |
| 62 | Retrobulbar optic neuritis (HP:0100654) | 2.22086544 |
| 63 | Optic neuritis (HP:0100653) | 2.22086544 |
| 64 | Recurrent bronchitis (HP:0002837) | 2.21877547 |
| 65 | Upper motor neuron abnormality (HP:0002127) | 2.20338579 |
| 66 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.19891821 |
| 67 | Chest pain (HP:0100749) | 2.19824248 |
| 68 | Diminished motivation (HP:0000745) | 2.19795099 |
| 69 | Abnormality of iron homeostasis (HP:0011031) | 2.19068855 |
| 70 | Abnormality of T cell number (HP:0011839) | 2.18360740 |
| 71 | Hypochromic microcytic anemia (HP:0004840) | 2.16769120 |
| 72 | Epistaxis (HP:0000421) | 2.14253473 |
| 73 | Urticaria (HP:0001025) | 2.11941707 |
| 74 | Abnormality of the prostate (HP:0008775) | 2.10686860 |
| 75 | Osteomyelitis (HP:0002754) | 2.10431910 |
| 76 | T lymphocytopenia (HP:0005403) | 2.10283320 |
| 77 | Apathy (HP:0000741) | 2.09557612 |
| 78 | Eosinophilia (HP:0001880) | 2.09162118 |
| 79 | Aplastic anemia (HP:0001915) | 2.08817797 |
| 80 | Hypergammaglobulinemia (HP:0010702) | 2.06611920 |
| 81 | Arterial thrombosis (HP:0004420) | 2.06304011 |
| 82 | Tetraparesis (HP:0002273) | 2.04632253 |
| 83 | Hypochromic anemia (HP:0001931) | 2.04488859 |
| 84 | Neurofibrillary tangles (HP:0002185) | 2.04030665 |
| 85 | Myocardial infarction (HP:0001658) | 2.02032042 |
| 86 | Meningitis (HP:0001287) | 2.00326091 |
| 87 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.99851816 |
| 88 | Abnormality of the pleura (HP:0002103) | 1.97930879 |
| 89 | Purpura (HP:0000979) | 1.97929358 |
| 90 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.96852169 |
| 91 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.96852169 |
| 92 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.96852169 |
| 93 | Granulocytopenia (HP:0001913) | 1.96481037 |
| 94 | Axonal loss (HP:0003447) | 1.96090897 |
| 95 | Hepatosplenomegaly (HP:0001433) | 1.94336237 |
| 96 | Global brain atrophy (HP:0002283) | 1.92054786 |
| 97 | Encephalitis (HP:0002383) | 1.91297815 |
| 98 | Loss of speech (HP:0002371) | 1.91076586 |
| 99 | Neuronal loss in central nervous system (HP:0002529) | 1.89798453 |
| 100 | Autoimmune hemolytic anemia (HP:0001890) | 1.87438413 |
| 101 | Personality changes (HP:0000751) | 1.87248287 |
| 102 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.86995998 |
| 103 | Chronic diarrhea (HP:0002028) | 1.85811601 |
| 104 | Amyloidosis (HP:0011034) | 1.85492797 |
| 105 | Keratoconjunctivitis sicca (HP:0001097) | 1.85170396 |
| 106 | Recurrent cutaneous fungal infections (HP:0011370) | 1.84491304 |
| 107 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.84491304 |
| 108 | Amaurosis fugax (HP:0100576) | 1.84085175 |
| 109 | Thoracic kyphosis (HP:0002942) | 1.83922265 |
| 110 | Nuclear cataract (HP:0100018) | 1.83538173 |
| 111 | Anorexia (HP:0002039) | 1.82423455 |
| 112 | Hemoptysis (HP:0002105) | 1.82145694 |
| 113 | Premature loss of primary teeth (HP:0006323) | 1.81196591 |
| 114 | Bone pain (HP:0002653) | 1.80979161 |
| 115 | Skin ulcer (HP:0200042) | 1.80696781 |
| 116 | Pathologic fracture (HP:0002756) | 1.79867426 |
| 117 | Polyneuropathy (HP:0001271) | 1.79723425 |
| 118 | Glomerulopathy (HP:0100820) | 1.79569985 |
| 119 | IgA deficiency (HP:0002720) | 1.79076677 |
| 120 | Fatigue (HP:0012378) | 1.79053809 |
| 121 | Gastrointestinal infarctions (HP:0005244) | 1.78957144 |
| 122 | Restrictive lung disease (HP:0002091) | 1.78918893 |
| 123 | Cardiomegaly (HP:0001640) | 1.75937792 |
| 124 | Inflammation of the large intestine (HP:0002037) | 1.75867219 |
| 125 | Mucosal telangiectasiae (HP:0100579) | 1.73862166 |
| 126 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.71735471 |
| 127 | Colitis (HP:0002583) | 1.71426114 |
| 128 | Splenomegaly (HP:0001744) | 1.71416585 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 3.47110361 |
| 2 | ERN1 | 3.44316402 |
| 3 | MAP4K1 | 2.94126817 |
| 4 | STK10 | 2.85703384 |
| 5 | MAP3K14 | 2.76754512 |
| 6 | TYK2 | 2.75912683 |
| 7 | CSF1R | 2.55072705 |
| 8 | BLK | 2.50804908 |
| 9 | TGFBR2 | 2.50209535 |
| 10 | JAK3 | 2.32768631 |
| 11 | PRPF4B | 2.32341731 |
| 12 | TBK1 | 2.20020341 |
| 13 | GRK6 | 2.19650867 |
| 14 | IRAK4 | 2.13092067 |
| 15 | KIT | 2.04487490 |
| 16 | IRAK3 | 1.97688419 |
| 17 | IKBKB | 1.90633987 |
| 18 | TXK | 1.79681155 |
| 19 | FGR | 1.75724370 |
| 20 | ZAP70 | 1.75502159 |
| 21 | FES | 1.73718177 |
| 22 | TAOK2 | 1.59947788 |
| 23 | NME2 | 1.57689776 |
| 24 | PIM2 | 1.54997842 |
| 25 | MATK | 1.49419836 |
| 26 | CSK | 1.47906454 |
| 27 | LRRK2 | 1.47371286 |
| 28 | MST4 | 1.44245558 |
| 29 | IKBKE | 1.42713051 |
| 30 | JAK1 | 1.41829113 |
| 31 | PDK2 | 1.36652147 |
| 32 | PAK4 | 1.34817356 |
| 33 | TAOK3 | 1.34511297 |
| 34 | FLT3 | 1.33330236 |
| 35 | ITK | 1.28442750 |
| 36 | SMG1 | 1.24894439 |
| 37 | MAP3K13 | 1.20617794 |
| 38 | BMPR2 | 1.20045801 |
| 39 | MAP2K3 | 1.19588333 |
| 40 | BTK | 1.19032325 |
| 41 | TEC | 1.17690444 |
| 42 | CHUK | 1.13852307 |
| 43 | MAP3K12 | 1.11505862 |
| 44 | NEK9 | 1.10448179 |
| 45 | MOS | 1.09751350 |
| 46 | GRK5 | 1.08919939 |
| 47 | RIPK4 | 1.07796202 |
| 48 | SYK | 1.06627515 |
| 49 | VRK2 | 1.03221634 |
| 50 | PIM1 | 1.02101463 |
| 51 | GRK7 | 1.00655703 |
| 52 | JAK2 | 1.00328237 |
| 53 | ADRBK2 | 1.00256119 |
| 54 | LCK | 0.98912119 |
| 55 | EPHB1 | 0.98785872 |
| 56 | FGFR3 | 0.98676782 |
| 57 | SCYL2 | 0.97481626 |
| 58 | PBK | 0.94047436 |
| 59 | RPS6KA4 | 0.93127564 |
| 60 | GRK1 | 0.91612221 |
| 61 | LYN | 0.90177916 |
| 62 | FGFR4 | 0.90042227 |
| 63 | SIK3 | 0.88844673 |
| 64 | CLK1 | 0.85979100 |
| 65 | HCK | 0.82105114 |
| 66 | ABL2 | 0.80485732 |
| 67 | BRSK2 | 0.80156841 |
| 68 | STK4 | 0.79892857 |
| 69 | MAP3K10 | 0.78190867 |
| 70 | PRKG2 | 0.77511064 |
| 71 | DDR2 | 0.74605660 |
| 72 | MAP3K8 | 0.72648326 |
| 73 | CDK7 | 0.72527903 |
| 74 | TESK2 | 0.71351836 |
| 75 | TTK | 0.69702971 |
| 76 | EPHA2 | 0.68713582 |
| 77 | MAP3K3 | 0.66921131 |
| 78 | EIF2AK1 | 0.66422089 |
| 79 | CDK4 | 0.65760162 |
| 80 | EIF2AK2 | 0.65560020 |
| 81 | MAP3K1 | 0.64470925 |
| 82 | RPS6KB2 | 0.64436100 |
| 83 | KDR | 0.64076684 |
| 84 | RIPK1 | 0.63942967 |
| 85 | NEK2 | 0.62222256 |
| 86 | TAOK1 | 0.61469933 |
| 87 | PASK | 0.60226241 |
| 88 | PKN2 | 0.59166553 |
| 89 | ACVR1B | 0.58609442 |
| 90 | MARK3 | 0.58173705 |
| 91 | YES1 | 0.57810858 |
| 92 | WEE1 | 0.57645540 |
| 93 | EIF2AK3 | 0.57636798 |
| 94 | CDC7 | 0.57170963 |
| 95 | CDK6 | 0.55075397 |
| 96 | MAP3K5 | 0.54939337 |
| 97 | PRKCD | 0.54893845 |
| 98 | MAPK7 | 0.53082420 |
| 99 | NEK1 | 0.52978785 |
| 100 | STK24 | 0.52792375 |
| 101 | HIPK2 | 0.52512198 |
| 102 | MAP3K11 | 0.52152982 |
| 103 | TTN | 0.49620144 |
| 104 | TRIB3 | 0.49276371 |
| 105 | BMX | 0.48797974 |
| 106 | MKNK1 | 0.48106629 |
| 107 | TESK1 | 0.47739684 |
| 108 | MAPKAPK2 | 0.47376138 |
| 109 | MKNK2 | 0.46417739 |
| 110 | TGFBR1 | 0.46163029 |
| 111 | DAPK1 | 0.46016080 |
| 112 | PRKCQ | 0.44326477 |
| 113 | BUB1 | 0.43873998 |
| 114 | SRPK1 | 0.43043355 |
| 115 | CDC42BPA | 0.42387956 |
| 116 | ALK | 0.42229989 |
| 117 | ARAF | 0.41820353 |
| 118 | TSSK6 | 0.41256555 |
| 119 | EEF2K | 0.40864108 |
| 120 | IRAK2 | 0.39845863 |
| 121 | LIMK1 | 0.38865638 |
| 122 | ATR | 0.38415485 |
| 123 | EGFR | 0.38317117 |
| 124 | PTK6 | 0.38231837 |
| 125 | CAMKK2 | 0.37804026 |
| 126 | ABL1 | 0.37110730 |
| 127 | IGF1R | 0.36416704 |
| 128 | TRPM7 | 0.36312519 |
| 129 | CAMK1D | 0.36047445 |
| 130 | FYN | 0.30294323 |
| 131 | PDPK1 | 0.29945177 |
| 132 | PDK1 | 0.29874868 |
| 133 | INSR | 0.28411979 |
| 134 | CDK19 | 0.26634697 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.68068237 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.34452110 |
| 3 | Legionellosis_Homo sapiens_hsa05134 | 2.28904553 |
| 4 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.17924935 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.14278024 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.12703032 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.08451279 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.05999651 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.96394042 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.95855251 |
| 11 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.92506928 |
| 12 | Measles_Homo sapiens_hsa05162 | 1.90205898 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.89520069 |
| 14 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.83318389 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.82600193 |
| 16 | DNA replication_Homo sapiens_hsa03030 | 1.81858753 |
| 17 | * Lysosome_Homo sapiens_hsa04142 | 1.74170737 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.72163361 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.71381090 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.62440987 |
| 21 | Malaria_Homo sapiens_hsa05144 | 1.61226255 |
| 22 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.59456546 |
| 23 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.59316103 |
| 24 | Pertussis_Homo sapiens_hsa05133 | 1.58616806 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.55727345 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.52615105 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.43739346 |
| 28 | Apoptosis_Homo sapiens_hsa04210 | 1.42358681 |
| 29 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.40956757 |
| 30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.39184418 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.39093720 |
| 32 | Asthma_Homo sapiens_hsa05310 | 1.38804056 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.36240886 |
| 34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.26448038 |
| 35 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.22415591 |
| 36 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.18092848 |
| 37 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.18009741 |
| 38 | Mismatch repair_Homo sapiens_hsa03430 | 1.13756009 |
| 39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.13099140 |
| 40 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.11304191 |
| 41 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.09935234 |
| 42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.09158112 |
| 43 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.07746998 |
| 44 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.07015636 |
| 45 | Shigellosis_Homo sapiens_hsa05131 | 1.05731502 |
| 46 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.05647776 |
| 47 | Proteasome_Homo sapiens_hsa03050 | 1.05299314 |
| 48 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.03437472 |
| 49 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.03171786 |
| 50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.00935907 |
| 51 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.98516178 |
| 52 | * Phagosome_Homo sapiens_hsa04145 | 0.94189825 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.92461742 |
| 54 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.91987592 |
| 55 | Salmonella infection_Homo sapiens_hsa05132 | 0.90033407 |
| 56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.86962030 |
| 57 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.85573251 |
| 58 | Hepatitis B_Homo sapiens_hsa05161 | 0.84566436 |
| 59 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.84346560 |
| 60 | Ribosome_Homo sapiens_hsa03010 | 0.83641023 |
| 61 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.82384716 |
| 62 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.79466513 |
| 63 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.78061446 |
| 64 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.77934365 |
| 65 | Hepatitis C_Homo sapiens_hsa05160 | 0.77777253 |
| 66 | Base excision repair_Homo sapiens_hsa03410 | 0.77614885 |
| 67 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.77201052 |
| 68 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.75658526 |
| 69 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.74452819 |
| 70 | Viral myocarditis_Homo sapiens_hsa05416 | 0.74005222 |
| 71 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.73413541 |
| 72 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.73282043 |
| 73 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.72582324 |
| 74 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.72513556 |
| 75 | RNA transport_Homo sapiens_hsa03013 | 0.72394806 |
| 76 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.72250198 |
| 77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.72023798 |
| 78 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.70557369 |
| 79 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70084152 |
| 80 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.68771409 |
| 81 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.66922142 |
| 82 | Homologous recombination_Homo sapiens_hsa03440 | 0.66653866 |
| 83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.65089666 |
| 84 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.62953157 |
| 85 | Bladder cancer_Homo sapiens_hsa05219 | 0.62379202 |
| 86 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.62042065 |
| 87 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58440324 |
| 88 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.55383078 |
| 89 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.53221099 |
| 90 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.53072511 |
| 91 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.52413394 |
| 92 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.50929862 |
| 93 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.50682320 |
| 94 | Prion diseases_Homo sapiens_hsa05020 | 0.49160786 |
| 95 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.46811782 |
| 96 | Spliceosome_Homo sapiens_hsa03040 | 0.45536670 |
| 97 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45530251 |
| 98 | Cell cycle_Homo sapiens_hsa04110 | 0.45353089 |
| 99 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.45176375 |
| 100 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.44983234 |
| 101 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.44399849 |
| 102 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44201426 |
| 103 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.44090718 |
| 104 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43272785 |
| 105 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.42201229 |
| 106 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.40189331 |
| 107 | HTLV-I infection_Homo sapiens_hsa05166 | 0.39926610 |
| 108 | RNA degradation_Homo sapiens_hsa03018 | 0.39429080 |
| 109 | Protein export_Homo sapiens_hsa03060 | 0.39245232 |
| 110 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.38800556 |
| 111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38285356 |
| 112 | Platelet activation_Homo sapiens_hsa04611 | 0.38267305 |
| 113 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.37959245 |
| 114 | Sulfur relay system_Homo sapiens_hsa04122 | 0.37074860 |
| 115 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.33854111 |
| 116 | Amoebiasis_Homo sapiens_hsa05146 | 0.33252919 |
| 117 | Endocytosis_Homo sapiens_hsa04144 | 0.31472428 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30991820 |
| 119 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.30140436 |
| 120 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.28382011 |
| 121 | Carbon metabolism_Homo sapiens_hsa01200 | 0.27049495 |

